IL1B and Hepatic fibrosis: These results corroborated an earlier study showing that anakinra reduced levels of IL-1β in mice with alcoholic liver disease (Petrasek et al., 2012), indicating that this inhibitor may be a potential treatment for alcohol-induced liver fibrosis.